Table 2 demonstrates the diagnostic performance of ACSL5, ACOT8, FASN, HMGCS2, and SCD1 as individual biomarkers for discriminating CRC tumors from the normal group. This evidence concerns the gene HMGCS2 and colorectal carcinoma.